Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, and the Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City Utah.

Corresponding author: Jasmin E. Charles, PA-C, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT; email: [email protected].

Financial Disclosure Funds were paid to University of Utah for Marcela C. Smid from Alydia Inc for being site PI for a study of the JADA device. Funds were paid to the University of Utah for Marcela C. Smid and Jasmin E. Charles from Gilead Science Inc for study of hepatitis C treatment in pregnancy. Dr. Smid also reports money was paid to her institution from NIDA and CDC and serving as a consultant for Rhia Ventures. The other authors did not report any conflicts of interest.

Each author has confirmed compliance with the journal's requirements for authorship.

Peer reviews and author correspondence are available at https://links.lww.com/AOG/D80.